Skip to main content
. 2020 Nov 26;14(1):15. doi: 10.3892/mco.2020.2177

Table I.

MUTYH and OGG1 germline variants identified in 59 patients with breast and ovarian cancer.

A, MUTYH
  Frequency n (%)  
Nucleotide change(s) Effect SNP Clinical significancea Cases (n=59) Controls (n=120) Word population MAFb Mutpred value
c.36+11C>T - rs2275602 VUS 1 (1.7) 0 (0) 0.01 -
c.53C>T Pro18Leu rs79777494 VUS 1 (1.7) 0 (0) <0.01 -
c.64G>A Val22Met rs3219484 N 2 (3.4) - 0.02 -
c.74G>A Gly25Asp rs75321043 VUS 1 (1.7) 0 (0) <0.01 -
c.157+30A>G - rs3219485 N 2 (3.4) - 0.01 -
c.504+35A>G - rs3219487 N 8 (13.6) - 0.06 -
c.701T>A Val234Gly - D/Novel 1 (1.7) 0 (0) - 0.798
c.1014 G>C Gln338His rs3219489 N 19(32) - 0.31 -
c.1171 G>T Val390Leu - Novel 1 (1.7) 0 (0) - 0.335
c.1431G>C Thr477Thr rs74318065 N 1 (1.7) 0 (0) 0.01 -
c.1477-40C>G - rs3219493 N 5 (8.5) - 0.06 -
B, OGG1
  Frequency n (%)  
Nucleotide change(s) Effect SNP Clinical significancea Cases (n=59) Controls (n=120) Word population MAFb Mutpred value
c.137 G>A Arg46Gln rs104893751 D 1 (1.7) 0 (0) <0.01 -
c.253G>A Ala85Thr rs17050550 VUS 1 (1.7) 0 (0) <0.01 -
c.384 G>A Gln128Gln - Novel 1 (1.7) 0 (0) - -
c.667G>A Ala223Thr - Novel 1 (1.7) 0 (0) - 0.095
c.899G>A Gly300Glu rs548981683 VUS 1 (1.7) 0 (0) <0.01 -
c.923 G>A Gly308Glu rs113561019 VUS 1 (1.7) 0 (0) <0.01 -
c.977 C>G Ser326Cys rs1052133 N 23(39) - 0.30 -

aResults based on the ClinVar-NCBI database.

bResults based on Ensembl genome browser 9. The pathogenicity of novel missense mutations was predicted using MutPred2 with a cut-off value of 0.61. D, deleterious; N, most likely neutral; VUS, variant of unknown clinical significance; SNP, single polymorphic nucleotide; MAF, minor allele frequency.